Cases 1 - 8 of 8
Allergan Inc et al v. Valeant Pharmaceuticals International Inc et al
as 8:2014cv01214
Defendant:
AGMS, Inc., William A. Ackman, Does and others
Counter Claimant:
William A. Ackman, PS Fund 1, LLC, Valeant Pharmaceuticals International AGMS Inc and others
Counter Defendant:
Allergan Inc, Deborah Dunsire, Michael R Gallagher and others
Plaintiff:
Allergan Inc and Karah H. Parschauer
Bryceland v. Minogue, et al
as 13-1914
Plaintiff - Appellant:
MARTA BRYCELAND, Derivatively on Behalf of Abiomed, Inc.
Defendant - Appellee:
MICHAEL R. MINOGUE, W. GERALD AUSTEN, LOUIS E. LATAIF and others
Bryceland v. Minogue et al
as 1:2013cv10212
Plaintiff:
Marta Bryceland
Defendant:
Michael R Minogue , W. Gerald Austen , Louis E Lataif and others
Cause Of Action: 28 U.S.C. § 1332 - Diversity: Securities & Exchange Commiss
Deka International S.A. Luxemb, et al v. Genzyme Corporation, et al
as 13-1085
Plaintiff:
VIVIAN OH, individually and on behalf of all others similarly situated, JON RAHN, individually and on behalf of all others similarly situated and GENZYME INSTITUTIONAL INVESTORS
Plaintiff - Appellant:
DEKA INTERNATIONAL S.A. LUXEMBOURG, CITY OF EDINBURGH COUNCIL AS ADMINISTERING AUTHORITY OF THE LOTHIAN PENSION FUND and GOVERNMENT OF GUAM RETIREMENT FUND
Defendant - Appellee:
DAVID P. MEEKER, MICHAEL S. WYZGA, GENZYME CORPORATION and others
Interested Party:
IRON WORKERS and HEAVY & GENERAL LABORERS' LOCALS 472 & 172 FUNDS, Institutional Investors
Ball v. Termeer et al
as 1:2009cv12198
Plaintiff:
Jack R Ball
Defendant:
Henri A Termeer, Michael S Wyzga, Richard A Moscicki and others
Cause Of Action: 15 U.S.C. § 78 m(a) Securities Exchange Act
In re GENZYME CORP. DERIVATIVE LITIGATION
as 1:2009cv12170
Plaintiff:
William Panzini and Edna Panzini
Defendant:
Henri A Termeer , Michael S Wyzga , Richard A Moscicki and others
Consolidated_plaintiff:
Jack R Ball
Cause Of Action: 15 U.S.C. § 78 m(a) Securities Exchange Act
Oh v. Genzyme Corporation et al
as 1:2009cv11299
Plaintiff:
Vivian Oh
Defendant:
Genzyme Corporation and Henri A. Termeer
Movant:
Genzyme Institutional Investors
Cause Of Action: 15 U.S.C. § 77 Securities Fraud
Rahn v. Genzyme Corporation et al
as 1:2009cv11267
Plaintiff:
Jon Rahn
Defendant:
Genzyme Corporation and Henri A Termeer
Cause Of Action: 15 U.S.C. § 77 Securities Fraud
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
